2022 CPhI North America

��ɫAV

Start

Tuesday, May 17, 2022 - 08:00

End

Thursday, May 19, 2022 - 17:00

Location: Philadelphia, USA

Booth Number: 723

��ɫAV present at the CPhI NA 2022 in Philadelphia

��

We are ready to safely return to��CPhI North America��in Philadelphia and we look forward to seeing you.

If you would like to connect face-to-face with ��ɫAV’s team at our booth (#723) or if you still prefer to meet us online, always count on our expert’s support.��,��our colleagues��will be pleased to meet you, both in-person or online.

��

��

��ɫAV offers the best chemistry,��particle engineering��and drug product capabilities all at the same location. With over 60 years’ experience in process development and manufacturing, we combine our innovative science, the most up-to-date technologies, and multidisciplinary teams to deliver the most impeccable end-to-end��solutions, enabling your projects to go to market faster.

��

Find more about CPhI North America

��

Lisbon, Portugal – ��ɫAV, the specialist integrated pharma CDMO and leader in spray drying and particle engineering, today announced its commitment to setting Science-Based Targets (SBTs) in line with the Paris Agreement. This ambitious step underscores the company’s dedication to addressing climate change and driving sustainability across its operations. By committing to SBTs, ��ɫAV joins a growing number of businesses taking concrete actions to reduce greenhouse gas emissions. This initiative aligns with the company’s broader sustainability strategy and reinforces its commitment to scientific excellence. “At ��ɫAV, we believe in science and in best practices. And this clearly applies to our sustainability agenda.”, said Jean-Luc Herbeaux, CEO of ��ɫAV. We made the decision to drive our GHG emissions down using a science-based target setting process, which will help us drive sustainability across our operations by laying out a clearly defined path to reduce emissions in line with the Paris Agreement goals. We believe that by setting ambitious targets and implementing concrete actions, we can make a positive impact on the planet while driving innovation and growth.” ��ɫAV will work closely with the Science Based Targets initiative (SBTi) to develop and validate its emission reduction targets. The company will provide regular updates on its progress towards achieving these goals. As part of its commitment to sustainability and transparency to stakeholders, the company will enhance its Ecovadis rating. Ecovadis, a leading sustainability assessment platform in the pharmaceutical industry, provides a comprehensive evaluation of a company’s environmental, social, and ethical performance, well aligned with ��ɫAV’s sustainability ambitions. ��ɫAV remains dedicated to operating responsibly and contributing positively to society and the environment. The company will continue to implement sustainable practices across its operations and innovate to further improve its sustainability rating. Learn more about Science Based-Targets

News

��ɫAV commitment to setting SBTs in line with the Paris Agreement

��ɫAV Commits to Science-Based Targets for Greenhouse Gas (GHG) Emissions

Sep 09, 2024

��ɫAV

Browser not supported

Press Room